A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Frontier Medicines Corporation
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Stanford University
Boehringer Ingelheim
Eli Lilly and Company
PMV Pharmaceuticals, Inc
Fred Hutchinson Cancer Center
Mayo Clinic
Eli Lilly and Company
Mayo Clinic
Tomsk National Research Medical Center of the Russian Academy of Sciences
National Institutes of Health Clinical Center (CC)
Incyte Corporation
University Hospital Heidelberg
BicycleTx Limited
Kivu Bioscience Inc.
University of Mississippi Medical Center
Alterome Therapeutics, Inc.
Verastem, Inc.
Ankyra Therapeutics, Inc
Daiichi Sankyo
M.D. Anderson Cancer Center
N-Power Medicine
M.D. Anderson Cancer Center
ViroMissile, Inc.
Eli Lilly and Company
AstraZeneca
Pfizer
Astellas Pharma Inc
Avenzo Therapeutics, Inc.
IntoCell, Inc
Pfizer
Pfizer
Tizona Therapeutics, Inc
Aulos Bioscience, Inc.
Essen Biotech
Essen Biotech
Mirati Therapeutics Inc.
InSilico Medicine Hong Kong Limited
ALX Oncology Inc.